Trials / Completed
CompletedNCT03557450
A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To evaluate if a commonly used medical bone scan, called positron emission tomography/computed tomography (PET/CT) with sodium fluoride can measure bone blood flow to the hip.
Detailed description
The purpose of this research is to validate technique on a commonly used medical bone scan, called positron emission tomography/computed tomography (PET/CT) along with sodium fluoride as the tracer for determining blood flow to the bone. Up to 12 subjects will have PET/CT scans so that we can determine the repeatability and reliability of the images prior to using PET/CT for this use on subjects in the Phase 1b part of Dr. Nancy Lane's clinical research study entitled "A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of the Safety and Tolerability of Intravenous LLP2A-Alendronate in Adult Men and Women with Osteopenia Secondary to Glucocorticoids" (IRB Protocol #866350).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PET/CT Scan | PET/CT scanning with sodium fluoride |
Timeline
- Start date
- 2018-06-11
- Primary completion
- 2019-03-25
- Completion
- 2019-03-25
- First posted
- 2018-06-15
- Last updated
- 2019-05-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03557450. Inclusion in this directory is not an endorsement.